Olawave-Plus Tablet contains a combination of Fluoxetine 20mg and Olanzapine 5mg, formulated for the treatment of major depressive disorder with psychotic features, treatment-resistant depression, and bipolar depression. Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), increases serotonin levels in the brain, thereby improving mood, appetite, and energy levels while decreasing anxiety and depressive symptoms. Olanzapine, an atypical antipsychotic, acts by modulating dopamine and serotonin receptors, helping to alleviate psychotic symptoms such as hallucinations, delusions, and mood instability. The synergistic effect of these two active ingredients provides enhanced therapeutic benefits in managing complex mood disorders where monotherapy may be insufficient. Olawave-Plus is indicated for adult patients under careful medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include weight gain, sedation, dry mouth, gastrointestinal disturbances, and extrapyramidal symptoms. Caution is advised in patients with a history of cardiovascular disease, diabetes, or seizure disorders. Regular monitoring of metabolic parameters and mental status is recommended during treatment. Olawave-Plus should not be abruptly discontinued to avoid withdrawal symptoms. This medication must be prescribed and used under the guidance of a qualified healthcare professional.

Dosage & How to Use